Literature DB >> 20428134

Clinical drug tests adapted for speed.

Heidi Ledford.   

Abstract

Mesh：

Year:  2010        PMID： 20428134     DOI： 10.1038/4641258a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Authors:  Ariel Lopez-Chavez; Anish Thomas; Arun Rajan; Mark Raffeld; Betsy Morrow; Ronan Kelly; Corey Allan Carter; Udayan Guha; Keith Killian; Christopher C Lau; Zied Abdullaev; Liqiang Xi; Svetlana Pack; Paul S Meltzer; Christopher L Corless; Alan Sandler; Carol Beadling; Andrea Warrick; David J Liewehr; Seth M Steinberg; Arlene Berman; Austin Doyle; Eva Szabo; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

2.  Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System.

Authors:  Tze L Lai; Philip W Lavori
Journal:  Stat Biosci       Date:  2011-12

3.  Clinical trial designs for testing biomarker-based personalized therapies.

Authors:  Tze Leung Lai; Philip W Lavori; Mei-Chiung I Shih; Branimir I Sikic
Journal:  Clin Trials       Date:  2012-03-07       Impact factor: 2.486

4.  Current state of clinical trials in breast cancer brain metastases.

Authors:  Jawad Fares; Deepak Kanojia; Alex Cordero; Aida Rashidi; Jason Miska; Charles W Schwartz; Solomiia Savchuk; Atique U Ahmed; Irina V Balyasnikova; Massimo Cristofanilli; William J Gradishar; Maciej S Lesniak
Journal:  Neurooncol Pract       Date:  2019-02-11

5.  Evaluating many treatments and biomarkers in oncology: a new design.

Authors:  Richard Kaplan; Timothy Maughan; Angela Crook; David Fisher; Richard Wilson; Louise Brown; Mahesh Parmar
Journal:  J Clin Oncol       Date:  2013-11-18       Impact factor: 44.544

6.  New generation of breast cancer clinical trials implementing molecular profiling.

Authors:  Dimitrios Zardavas; Martine Piccart-Gebhart
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.